Loading…
As of 9 Nov 2026: AksharChem India ₹368.20 (m-cap ₹295 Cr) vs YCCL ₹12.20 (m-cap ₹23.55 Cr, P/E 24.4). Compare ROE, ROCE, growth, debt, dividends and 1-year returns.
As of · NSE prices; ratios from company filings
| Metric | AksharChem India | YCCL |
|---|---|---|
| Share price | ₹368.20 | ₹12.20 |
| Day change | +2.41% | +19.61% |
| Market cap | ₹295 Cr | ₹23.55 Cr |
| P/EPrice ÷ trailing 12-month earnings per share; blank for a loss. | — | 24.4 |
| P/BPrice ÷ book value per share. | 1.1 | 0.6 |
| ROEReturn on equity. | -0.8% | 2.3% |
| ROCEReturn on capital employed. | 0.0% | 5.3% |
| Sales growth (3Y CAGR) | 3.7% | 38.1% |
| Profit growth (3Y CAGR) | — | -35.0% |
| Debt to equity | 0.41 | 0.32 |
| Dividend yield | 0.14% | 0.00% |
| 1-year price return | +46.6% | −6.2% |
| Promoter holding | 62.7% | 51.5% |
| Industry | Dyes And Pigments | Dyes And Pigments |
Open in the compare tool for price charts from one month to five years, scorecards and more companies.
Each line states which company has the higher or lower figure; none of them is a recommendation.
AksharChem (India) Ltd is larger, with a market cap of ₹295 Cr against ₹23.55 Cr for Yasons Chemex Care Ltd as of 9 Nov 2026 — about 12.5 times the size.
AksharChem (India) Ltd has no meaningful P/E right now (a loss over the last twelve months, or no reported earnings), so the two cannot be compared on P/E.
Jivani Markets does not give buy, sell or hold recommendations and is not a SEBI-registered investment adviser or research analyst. The table on this page lays out the facts side by side — price, valuation, returns on capital, growth, debt, dividends and promoter holding — so you can weigh them against your own goals, or with a SEBI-registered adviser.
Prices refresh every few minutes during market hours (delayed by up to 15 minutes) and ratios update when the companies report results. Each number is the same one shown on the two stock pages.